Meniere Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Meniere disease is a disorder of the inner ear that causes spontaneous episodes of vertigo. Signs and symptoms of Meniere disease are hearing loss, tinnitus and feeling of fullness in the ear. Causes include allergies, viral infection, head trauma and migraines.
The Meniere disease – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Meniere disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Meniere disease and features dormant and discontinued projects.
Key Targets in the Meniere disease Pipeline Drugs Market
The key targets in the Meniere disease pipeline drugs market are Glucocorticoid Receptor, Caspase 2, Glutathione Peroxidase, and Prostaglandin F2 Alpha Receptor among others.
Meniere disease Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Meniere disease Pipeline Drugs Market
The key mechanisms of action in the Meniere disease pipeline drugs market are Glucocorticoid Receptor Agonist, Caspase 2 Inhibitor, Glutathione Peroxidase Activator, and Prostaglandin F2 Alpha Receptor Agonist among others.
Meniere disease Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Meniere disease Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Meniere disease pipeline drugs market are Intratympanic, and Oral.
Meniere disease Pipeline Drugs Market, by RoA
For more company insights, download a free sample report
Key Molecule Types in the Meniere disease Pipeline Drugs Market
The key molecule types in the Meniere disease pipeline drugs market are Antisense RNAi Oligonucleotide, and Small Molecule.
Meniere disease Pipeline Drugs Market, by Molecule Type
For more company insights, download a free sample report
Major Companies in the Meniere disease Pipeline Drugs Market
The major companies in the Meniere disease pipeline drugs market are Adare Pharma Solutions, Apsen Farmaceutica SA, IntraBio Ltd, Quark Pharmaceuticals Inc, Sound Pharmaceuticals Inc, Spiral Therapeutics Inc, Steel Therapeutics Inc, and Synphora AB among others.
Meniere disease Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Meniere disease Pipeline Drugs Market Overview
Key Targets | Glucocorticoid Receptor, Caspase 2, Glutathione Peroxidase, and Prostaglandin F2 Alpha Receptor |
Key Mechanisms of action | Glucocorticoid Receptor Agonist, Caspase 2 Inhibitor, Glutathione Peroxidase Activator, and Prostaglandin F2 Alpha Receptor Agonist |
Key Routes of Administration | Intratympanic, and Oral |
Key molecule types | Antisense RNAi Oligonucleotide, and Small Molecule |
Major companies | Adare Pharma Solutions, Apsen Farmaceutica SA, IntraBio Ltd, Quark Pharmaceuticals Inc, Sound Pharmaceuticals Inc, Spiral Therapeutics Inc, Steel Therapeutics Inc, and Synphora AB |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Meniere disease
- The pipeline guide reviews pipeline therapeutics for Meniere disease by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Meniere disease therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Meniere disease therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Meniere disease
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Meniere disease
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Meniere disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Apsen Farmaceutica SA
IntraBio Ltd
Quark Pharmaceuticals Inc
Sound Pharmaceuticals Inc
Spiral Therapeutics Inc
Steel Therapeutics Inc
Synphora AB
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Meniere disease pipeline drugs market?
The key targets in the Meniere disease pipeline drugs market are Glucocorticoid Receptor, Caspase 2, Glutathione Peroxidase, and Prostaglandin F2 Alpha Receptor.
-
What are the key mechanisms of action in the Meniere disease pipeline drugs market?
The key mechanisms of action in the Meniere disease pipeline drugs market are Glucocorticoid Receptor Agonist, Caspase 2 Inhibitor, Glutathione Peroxidase Activator, and Prostaglandin F2 Alpha Receptor Agonist.
-
What are the key routes of administration in the Meniere disease pipeline drugs market?
The key routes of administration in the Meniere disease pipeline drugs market are Intratympanic, and Oral.
-
What are the key molecule types in the Meniere disease pipeline drugs market?
The key molecule types in the Meniere disease pipeline drugs market are Antisense RNAi Oligonucleotide, and Small Molecule.
-
What are the major companies in the Meniere disease pipeline drugs market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.